Sino Biopharmaceutical Statistics Share Statistics Sino Biopharmaceutical has 17.88B
shares outstanding. The number of shares has increased by -2.47%
in one year.
Shares Outstanding 17.88B Shares Change (YoY) -2.47% Shares Change (QoQ) -2.47% Owned by Institutions (%) n/a Shares Floating 9.27B Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 20.15M, so 0% of the outstanding
shares have been sold short.
Short Interest 20.15M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 999.99
Valuation Ratios The PE ratio is 14.78 and the forward
PE ratio is 4.22.
Sino Biopharmaceutical's PEG ratio is
0.1.
PE Ratio 14.78 Forward PE 4.22 PS Ratio 1.79 Forward PS 0.5 PB Ratio 1.62 P/FCF Ratio 0 PEG Ratio 0.1
Financial Ratio History Enterprise Valuation Sino Biopharmaceutical has an Enterprise Value (EV) of 51.94B.
EV / Sales 1.8 EV / EBITDA 8.5 EV / EBIT 0 EV / FCF 0
Financial Position The company has a current ratio of 1.26,
with a Debt / Equity ratio of 0.31.
Current Ratio 1.26 Quick Ratio 1.14 Debt / Equity 0.31 Debt / EBITDA 1.6 Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is 10.95% and Return on Invested Capital is 10.63%.
Return on Equity 10.95% Return on Assets 5.35% Return on Invested Capital 10.63% Revenue Per Employee $1.18M Profits Per Employee $143.56K Employee Count 24,379 Asset Turnover 0.44 Inventory Turnover 2.25
Taxes Income Tax 492.92M Effective Tax Rate 9.34%
Stock Price Statistics The stock price has increased by 182.69% in the
last 52 weeks. The beta is 0.64, so Sino Biopharmaceutical's
price volatility has been higher than the market average.
Beta 0.64 52-Week Price Change 182.69% 50-Day Moving Average 0.74 200-Day Moving Average 0.52 Relative Strength Index (RSI) 74.09 Average Volume (20 Days) 1,345
Income Statement In the last 12 months, Sino Biopharmaceutical had revenue of 28.87B
and earned 3.5B
in profits. Earnings per share was 0.2.
Revenue 28.87B Gross Profit 23.53B Operating Income 6.28B Net Income 3.5B EBITDA 6.11B EBIT 5.17B Earnings Per Share (EPS) 0.2
Full Income Statement Balance Sheet The company has 9.57B in cash and 9.78B in
debt, giving a net cash position of -214.26M.
Cash & Cash Equivalents 9.57B Total Debt 9.78B Net Cash -214.26M Retained Earnings n/a Total Assets 65.41B Working Capital 5.13B
Full Balance Sheet Margins Gross margin is 81.51%, with operating and profit margins of 21.76% and 12.12%.
Gross Margin 81.51% Operating Margin 21.76% Pretax Margin 18.28% Profit Margin 12.12% EBITDA Margin 21.16% EBIT Margin 21.76% FCF Margin n/a
Dividends & Yields SBMFF pays an annual dividend of $0.01,
which amounts to a dividend yield of 1.33%.
Dividend Per Share $0.01 Dividend Yield 1.33% Dividend Growth (YoY) 32.7% Payout Ratio 89.4% Earnings Yield 6.77% FCF Yield 0%
Dividend Details Analyst Forecast Currently there are no analyst rating for SBMFF.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $1 Lynch Upside 4.17% Graham Number 2.91 Graham Upside 203.13%
Stock Splits The last stock split was on Jul 20, 2020. It was a
forward
split with a ratio of 3:2.
Last Split Date Jul 20, 2020 Split Type forward Split Ratio 3:2
Scores Altman Z-Score 1.24 Piotroski F-Score 6
